Sucralfate Suspension
Product Images NDC 50268-745

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 50268-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (50268 745 11)

The image shows the round peel-off label for Sucralfate Oral Suspension 1 g/10 mL by AvPAK. It includes dosing instructions to deliver 10 mL and storage temperature (20° to 25°C, 68° to 77°F). It has a barcode, manufacturer information, and advises shaking well before use. The product is Rx only.*

FDA Label Image

40 (745 14)

Label for Sucralfate Oral Suspension 1 g/10 mL by AvPAK, a human prescription drug in oral suspension form. The label states it delivers 10 mL per dose, includes storage instructions (store at 20° to 25°C), and cautions to shake well and avoid freezing. The label also shows the NDC 50268-745-14 and manufacturing location in Pulaski, TN.*

FDA Label Image

Chemical Structure (Sucralfate Oral Suspension 1)

Chemical structure of Sucralfate, showing its molecular framework including hydroxyl and sulfoaluminate groups with associated formula details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.